A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults

NCT01215149 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults

NCT01964937 ·Status: WITHDRAWN ·Phase: PHASE1

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

NCT00001096 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

NCT02852005 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa

NCT00498056 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

NCT00000904 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults

NCT01799954 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Immune Response Study of 2 Experimental HIV Vaccines

NCT02404311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines

NCT00000746 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand

NCT00006327 ·Status: COMPLETED ·Phase: PHASE3

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

NCT00004579 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States

NCT03382418 ·Status: COMPLETED ·Phase: PHASE1

Vaccine Treatment for HIV-Infection

NCT00108654 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)

NCT01423825 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

NCT00415649 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

NCT00001044 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

NCT01927835 ·Status: WITHDRAWN ·Phase: PHASE1

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

NCT00124007 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

NCT00083603 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Safety Study of Two Experimental HIV Vaccines

NCT00479999 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults

NCT02771730 ·Status: TERMINATED ·Phase: PHASE1

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

NCT00002231 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)

NCT00001021 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

NCT00001052 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

NCT00574600 ·Status: COMPLETED ·Phase: PHASE1